IL314458A - Protein z variants binding thymic stromal lymphopoietin and their medical use - Google Patents

Protein z variants binding thymic stromal lymphopoietin and their medical use

Info

Publication number
IL314458A
IL314458A IL314458A IL31445824A IL314458A IL 314458 A IL314458 A IL 314458A IL 314458 A IL314458 A IL 314458A IL 31445824 A IL31445824 A IL 31445824A IL 314458 A IL314458 A IL 314458A
Authority
IL
Israel
Prior art keywords
protein
medical use
thymic stromal
stromal lymphopoietin
variants binding
Prior art date
Application number
IL314458A
Other languages
Hebrew (he)
Original Assignee
Affibody Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affibody Ab filed Critical Affibody Ab
Publication of IL314458A publication Critical patent/IL314458A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL314458A 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use IL314458A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22155646 2022-02-08
PCT/EP2023/053030 WO2023152144A1 (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Publications (1)

Publication Number Publication Date
IL314458A true IL314458A (en) 2024-09-01

Family

ID=80682629

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314458A IL314458A (en) 2022-02-08 2023-02-08 Protein z variants binding thymic stromal lymphopoietin and their medical use

Country Status (10)

Country Link
EP (1) EP4476247A1 (en)
JP (1) JP2025506381A (en)
KR (1) KR20240139058A (en)
CN (1) CN118632866A (en)
AR (1) AR128475A1 (en)
AU (1) AU2023218534A1 (en)
CA (1) CA3251231A1 (en)
IL (1) IL314458A (en)
MX (1) MX2024009732A (en)
WO (1) WO2023152144A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE08786222T1 (en) 2007-07-31 2010-11-25 Affibody Ab NEW ALBUMIN BINDING COMPOSITIONS, PROCESSES AND APPLICATIONS
ES2373832T3 (en) 2007-12-19 2012-02-09 Affibody Ab POLYPEPTIDE DERIVED FROM PROTEIN A AND ABLE TO JOIN PDGF.
BR112013000452A2 (en) 2010-07-09 2020-02-11 Affibody Ab ALBUMIN BINDING POLYPEPTIDE, FUSION OR CONJUGATE PROTEIN, POLYNUCLEOTIDE, METHOD TO PRODUCE A POLYPEPTIDE, COMPOSITION, METHOD FOR THE PREPARATION OF A COMPOSITION, AND, METHOD FOR INCREASING THE SOLUBILITY OF A SOLUBILITY
US10155792B2 (en) 2012-09-25 2018-12-18 Affibody Ab Albumin binding polypeptide
WO2015189430A1 (en) 2014-06-13 2015-12-17 Affibody Ab New polypeptide
KR20240110106A (en) * 2015-01-12 2024-07-12 애피바디 에이비 Il-17a-binding polypeptides
CA3001264A1 (en) 2015-10-30 2017-05-04 Affibody Ab Pd-l1 binding polypeptide
WO2021089695A1 (en) * 2019-11-05 2021-05-14 Affibody Ab Polypeptides

Also Published As

Publication number Publication date
AU2023218534A1 (en) 2024-07-11
CN118632866A (en) 2024-09-10
AR128475A1 (en) 2024-05-15
CA3251231A1 (en) 2023-08-17
WO2023152144A1 (en) 2023-08-17
KR20240139058A (en) 2024-09-20
EP4476247A1 (en) 2024-12-18
MX2024009732A (en) 2024-08-19
JP2025506381A (en) 2025-03-11

Similar Documents

Publication Publication Date Title
ZA202110236B (en) Antibody capable of binding to thymic stromal lymphopoietin and use thereof
EP4119162A4 (en) Pvrig binding protein and its medical uses
EP4106806A4 (en) Flt3 binding proteins and methods of use
IL250900A0 (en) Antigen binding proteins capable of binding thymic stromal lymphopoietin
IL182422A0 (en) Prion protein binding materials and methods of use
IL316176A (en) Siglec-8 binding proteins and uses thereof
LT4051708T (en) Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof
IL327193A (en) Cas12 protein and use thereof
ZA202109744B (en) Anti-connective tissue growth factor antibody and application thereof
HK40118530A (en) Protein z variants binding thymic stromal lymphopoietin and their medical use
PL371773A1 (en) Modified human thymic stromal lymphopoietin
EP4499703A4 (en) ANTIBODIES AGAINST HUMAN SIGLEC-9 AND THEIR USE FOR IMMUNOTHERAPY
EP3958765C0 (en) Dorsal vertebral fusion set and medical tool handle
IL308973A (en) Anti-ctla-4 binding proteins and methods of use thereof
IL314129A (en) Materials and methods of il-1beta binding proteins
EP4446335A4 (en) Novel peptide and use thereof
EP4212551A4 (en) Antibody binding human il-5r? and use thereof
EP4056584A4 (en) NOVEL HUMAN EPIDERMAL GROWTH FACTOR-TF FUSION PROTEIN AND USE THEREOF
CA3310396A1 (en) Trgv9 binding proteins and medical use thereof
AU2024379650A1 (en) Trgv9 binding proteins and medical use thereof
EP4119666A4 (en) LIGHT-SENSITIVE PROTEIN FOR COLOUR RECOGNITION AND ITS USE
HK40130669A (en) Il-36r binding protein and medicinal use thereof
CA3283398A1 (en) Il-36r binding protein and medicinal use thereof
IL290649A (en) cr2 binding proteins and their use in medical treatment
IL275186A (en) Human anti-grp94 antibodies and uses